Pacira Pharmaceuticals

10450 Science Center Drive
San Diego, CA 92121
(858) 625 2424

5 Sylvan Way
Parsippany, NJ 07054
(973) 254 3560

The product is currently marketed in the U.S. by EKR Therapeutics. DepoDur® was approved by the FDA in May 2004 and launched in December.

Flynn Pharma markets DepoDur® in U.K., and continues to expand marketing approvals in the EU. The U.K. granted marketing authorization in 2006.

All global supply requirements for DepoDur® are being met by Pacira's two cGMP manufacturing facilities in San Diego, CA.